Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oragenics Inc (NYSE MKT LLC:OGEN)

0.5394
Delayed Data
As of 12:57pm ET
 +0.0094 / +1.77%
Today’s Change
0.43
Today|||52-Week Range
2.33
-64.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues1.3M1.0M939.9K1.2M
 
 
 
 
 
Cost of Goods Sold878.5K343.4K341.9K410.6K
 
 
 
 
 
Depreciation And Amortization75.2K76.5K27.7K71.2K
 
 
 
 
 
 
Operating ExpensesGross Income378.1K612.4K570.3K694.1K
 
 
 
 
 
General Expenses12.8M16.8M6.4M12.3M
 
 
 
 
 
Research And Development7.8M9.3M3.1M8.8M
 
 
 
 
 
Total Operating Expenses13.8M17.2M6.8M12.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.4M-16.2M-5.8M-11.7M
 
 
 
 
 
Interest Expense On Debt655.6K17.5K4.0K76.7K
 
 
 
 
 
Other Expenses-17.8K135.5K-6.0K-3.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.1M-16.1M-5.8M-11.7M
 
 
 
 
 
Net Income-13.1M-16.1M-5.8M-11.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.7M28.8M36.2M36.7M
 
 
 
 
 
Shares To Calculate EPS Diluted17.7M28.8M36.2M36.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.74-$0.56-$0.16-$0.32
 
 
 
 
 
EPS Diluted-$0.74-$0.56-$0.16-$0.32